Author

Christopher R. Reilly

Dana-Farber Cancer InstituteORCID 0000-0002-9551-7533Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:statistical model· 1 Research Focus:variant effect prediction· 1

Frequent Co-Authors

Daniel J. DeAngeloiD· 2 shared Donna S NeubergiD· 2 shared Amulya Jakkani· 1 shared Andrew A. LaneiD· 1 shared Anthony G. LetaiiD· 1 shared Christopher James GibsoniD· 1 shared Corey S. CutleriD· 1 shared Druha Karunakaran· 1 shared

Activity by Year

2021-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Daniel J. DeAngeloORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintOct 14, 2025

Dynamic BH3 profiling predicts clinical outcomes in acute myeloid leukemia

Emma Minihane, Leah Krotee, Jason H. Y. Wu…·Jacqueline Suen Garcia

This paper uses Dynamic BH3 Profiling to predict clinical outcomes in AML by assessing drug-induced apoptotic priming in patient samples.

2 citations

humanexperimental assay

𝕏 PostBluesky

GeneticsBloodPeer-reviewedMay 21, 2021

The clinical and functional effects of TERT variants in myelodysplastic syndrome

Christopher R. Reilly, Mikko Myllymäki, Robert Allyn Redd…·Robert Coleman Lindsley

The paper identifies TERT rare variants in MDS patients, showing shorter telomeres, younger age at diagnosis, and worse survival, suggesting their role in MDS pathogenesis and transplant outcomes.

51 citationstop 3%

humanstatistical model

𝕏 PostBluesky